BioLife Solutions, Inc.
BLFS
$25.65
-$0.26-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 95.62% | 183.30% | 94.15% | -- |
| Total Depreciation and Amortization | -- | -39.24% | 35.76% | -27.07% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -25.45% | -171.94% | -77.07% | -- |
| Change in Net Operating Assets | -- | -42.55% | -84.02% | 39.59% | -- |
| Cash from Operations | 14.07% | 138.59% | -28.82% | 209.66% | 183.69% |
| Capital Expenditure | -- | 48.17% | 66.36% | 35.42% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -4,565.94% | 1,073.93% | -103.28% | -- |
| Cash from Investing | -194.25% | -12,196.83% | 1,760.93% | -201.14% | -244.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -937.34% | -1,951.89% | -535.60% | -- |
| Issuance of Common Stock | -- | -- | -99.37% | -28.13% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 30.80% | 0.00% | 67.56% | -- |
| Cash from Financing | -308.81% | -214.29% | -141.52% | -271.22% | -200.00% |
| Foreign Exchange rate Adjustments | -- | -- | -53.97% | 164.29% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -356.29% | -397.83% | 340.42% | 197.74% | -434.64% |